APA (7th ed.) Citation

XW, H., DJ, W., & BZ, C. (2026). Impact of tumor mutation burden on the prognosis of patients with unresectable hepatocellular carcinoma undergoing transcatheter arterial chemoembolization combined with immunotherapy and anti-angiogenic drugs. Journal of gastrointestinal oncology, 17(2), 74. https://doi.org/10.21037/jgo-2025-aw-930

Chicago Style (17th ed.) Citation

XW, Huang, Wang DJ, and Cai BZ. "Impact of Tumor Mutation Burden on the Prognosis of Patients with Unresectable Hepatocellular Carcinoma Undergoing Transcatheter Arterial Chemoembolization Combined with Immunotherapy and Anti-angiogenic Drugs." Journal of Gastrointestinal Oncology 17, no. 2 (2026): 74. https://doi.org/10.21037/jgo-2025-aw-930.

MLA (9th ed.) Citation

XW, Huang, et al. "Impact of Tumor Mutation Burden on the Prognosis of Patients with Unresectable Hepatocellular Carcinoma Undergoing Transcatheter Arterial Chemoembolization Combined with Immunotherapy and Anti-angiogenic Drugs." Journal of Gastrointestinal Oncology, vol. 17, no. 2, 2026, p. 74, https://doi.org/10.21037/jgo-2025-aw-930.